Email this article Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay)
- Authors: Elizbaryan KS1, Kazantseva MV1, Davidenko IS1, Potemin SN1, Andreev DV1, Burdik OP1, Stukan' AI1
-
Affiliations:
- Issue: Vol 14, No 3 (2012)
- Pages: 77-80
- Section: Articles
- URL: https://modernonco.orscience.ru/1815-1434/article/view/29513
- ID: 29513
Cite item
Full Text
Abstract
About the authors
K S Elizbaryan
M V Kazantseva
I S Davidenko
S N Potemin
D V Andreev
O P Burdik
A I Stukan'
References
- Glynne-Jones R, Northover J, Oliveira J. ESMO Guidelines Working Group. Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl. 4): 57-60.
- Frisch M, Glimelius B, van den Brule AJ et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.
- Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist 2007; 12: 524-34.
- Ortholan C, Ramaioli A, Peiffert D et al. Anal canal carcinoma: early - stage tumors ≤10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 479-85.
- Das P, Crane C, Ajani J. Current treatment of localized anal carcinoma. Curr Opin Oncol 2007; 19: 396-400.
- Buchs NC, Allal AS, Morel P, Gervaz P. Prevention, chemoradiation and surgery for anal cancer. Expert Rev Anticancer Ther 2009; 9: 483-9.
- Conroy T, Ducreux M, Lemanski C et al. Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): Definitive analysis of the intergroup ACCORD 03 trial (abstract). J Clin Oncol 2009; 27 (Suppl. 15 s): 4033.
- Zilli T, Schick U, Ozsahin M et al. Node-negative T1-T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy? Radiother Oncol 2011.
- Graf R, Wust P, Hildebrandt B et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003; 65: 14-22.
- Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008; 299: 1914-21.
- Вazan JG, Hara W, Hsu A et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer 2011; 117: 3342.
- Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 2008; 299: 1914-21.
- Van Damme N, Deron P, Van Roy N et al. Epidermal growth factor receptor and K-RAS stasus in two cohorts of squamous cell carcinomas. BMC Cancer 2010; 10: 189.
- Zampino MG, Magni E, Sonzogni A, Renne G. K-Ras status in squamous cell anal carcinoma (SCC): it's time for target oriented treatment? Cancer Chemother Pharmacol 2009; 65:197-9.
Supplementary files
